Does AFFF Firefighting Foam Cause Testicular Cancer? A Review of the Evidence

From General Health to Occupational Exposure

Historically, the domain of general health and science information has served as a foundational resource for public understanding of disease prevention and environmental risk factors. This legacy context provides a broad framework for interpreting how external agents may influence human health, often focusing on lifestyle, nutrition, and common environmental exposures. Within this established paradigm, the transition to occupational health concerns represents a natural extension, moving from population-level guidance to specific, high-risk work environments. The shift is particularly relevant when examining persistent chemical exposures encountered by professionals in industrial and emergency response settings. Firefighting, as a profession, involves routine contact with complex chemical mixtures, including aqueous film-forming foam (AFFF) used for extinguishing flammable liquid fires. This occupational context introduces a distinct exposure profile that differs markedly from general environmental or consumer product contact. The pivot from general health literacy to occupational exposure concern thus reframes the inquiry: rather than asking about broad, diffuse risks, the focus narrows to a defined workforce with repeated, high-concentration contact. This transition sets the stage for examining whether such specific, prolonged occupational exposure to AFFF may be associated with elevated health risks, including testicular cancer, without yet delving into mechanistic or causal claims.

Bridging to the Medical Evidence

Building on the occupational context, we now turn to the medical and scientific evidence regarding AFFF and testicular cancer. AFFF contains per- and polyfluoroalkyl substances (PFAS), a class of highly stable synthetic organic compounds that have been detected ubiquitously in human biological samples (https://pubmed.ncbi.nlm.nih.gov/42221197/). The question of whether AFFF exposure causes testicular cancer requires examination of mechanistic, epidemiological, and clinical evidence. This section synthesizes the available research to provide a balanced assessment of the potential link.

Mechanistic Pathways: PFAS Accumulation in Testicular Tissue

Preclinical research demonstrates that PFAS accumulate in testicular tissue. One study confirmed that testicular accumulation of PFAS is correlated with compromised rates of sperm production and alterations to the sperm epigenome, though overall fertility and behavioral outcomes were not compromised in PFAS-exposed males (https://pubmed.ncbi.nlm.nih.gov/42019663/). These findings suggest a biological plausibility for PFAS to disrupt male reproductive function at the cellular level, which could theoretically contribute to carcinogenesis. However, the same study noted that negative effects were more pronounced in F1 offspring compared with subsequent F2 and F3 generations, indicating that the risk posed by PFAS is not amplified across three generations (https://pubmed.ncbi.nlm.nih.gov/42019663/).

Epidemiological Evidence: Associations and Limitations

A systematic review and meta-analysis examined case-control or cohort studies that assessed associations between serum or plasma exposure to five PFAS (perfluorooctanoic acid [PFOA], perfluorooctane sulfonic acid [PFOS], perfluorohexane sulfonic acid [PFHxS], perfluorononanoic acid [PFNA], and perfluorinated sulfonic acids [PFSA]) and reproductive system cancers, including testicular cancer (https://pubmed.ncbi.nlm.nih.gov/42221197/). The analysis included 21 case-control studies. Pooled adjusted odds ratios (aORs) comparing highest to lowest exposure showed no significant association between PFAS exposure and female reproductive cancers. For male reproductive cancers, PFOS showed a marginal positive association (aOR 1.25, 95% CI 1.02-1.52), whereas PFOA showed no association (aOR 0.87, 95% CI 0.65-1.17) (https://pubmed.ncbi.nlm.nih.gov/42221197/). The authors concluded that overall serum PFAS exposure was not significantly associated with female reproductive cancers, though PFOS may be associated with increased risk for male reproductive cancers (https://pubmed.ncbi.nlm.nih.gov/42221197/). Additional evidence comes from a large population-based study covering 34 years (1985 to 2018) in a region with documented PFAS water contamination. In the resident population, researchers observed 51,621 deaths versus 47,731 expected (age- and sex-standardized mortality ratio 108; 90% CI 107-109). They found evidence of raised mortality from malignant neoplastic diseases, including kidney cancer and testicular cancer, and noted that the evidence regarding testicular cancer is consistent with previously reported data (https://pubmed.ncbi.nlm.nih.gov/38627679/). This study provides ecological-level support for an association between PFAS exposure and testicular cancer mortality.

Clinical Presentation and Diagnosis of Testicular Cancer

Testicular cancer typically presents as a painless lump or swelling in one testicle, often discovered by the patient or during a routine physical examination. Diagnosis involves ultrasound imaging, serum tumor markers (alpha-fetoprotein, beta-human chorionic gonadotropin, lactate dehydrogenase), and ultimately radical inguinal orchiectomy for histopathological confirmation. The disease is highly treatable, with cure rates exceeding 95% when detected early.

Causation Considerations and Risk Context

For affected patients, causation considerations involve the strength of association, consistency across studies, biological plausibility, and temporal relationship. The epidemiological data show a marginal association for PFOS but not for other PFAS, and the evidence is not consistent across all studies. The meta-analysis found no significant association for most PFAS examined (https://pubmed.ncbi.nlm.nih.gov/42221197/). The ecological study provides supporting evidence but cannot establish individual-level causation (https://pubmed.ncbi.nlm.nih.gov/38627679/). Regarding adequacy of warnings, the evidence does not indicate that AFFF manufacturers provided specific warnings about testicular cancer risk. The temporal relationship between exposure and documented harm is difficult to establish precisely, but the ecological study suggests that effects may be observed over decades (34-year follow-up) (https://pubmed.ncbi.nlm.nih.gov/38627679/). The preclinical data indicate that PFAS accumulate in testicular tissue and affect reproductive function, but the direct carcinogenic mechanism remains unclear (https://pubmed.ncbi.nlm.nih.gov/42019663/). Current evidence suggests a possible but not definitive causal link between AFFF PFAS exposure and testicular cancer. The strongest epidemiological support comes from a marginal association with PFOS and ecological data showing increased testicular cancer mortality in PFAS-contaminated areas. Mechanistic studies confirm testicular accumulation and reproductive effects but do not establish a direct carcinogenic pathway. Patients with testicular cancer and AFFF exposure history should discuss these findings with their healthcare providers, recognizing that the evidence is evolving and does not yet support a clear causal conclusion.

Important Notice

This page is for educational and informational purposes only. It does not provide medical diagnosis, treatment, or legal advice. Consult licensed clinicians and qualified attorneys for case-specific decisions.

Frequently Asked Questions

What is AFFF firefighting foam and why is it a concern?

AFFF (aqueous film-forming foam) is used to extinguish flammable liquid fires. It contains per- and polyfluoroalkyl substances (PFAS), which are persistent chemicals that can accumulate in the body. Occupational exposure in firefighters has raised concerns about potential health risks, including testicular cancer.

Is there a proven causal link between AFFF exposure and testicular cancer?

Current evidence suggests a possible but not definitive causal link. Epidemiological studies show a marginal association for PFOS (a type of PFAS) and ecological data indicate increased testicular cancer mortality in PFAS-contaminated areas. However, meta-analyses found no significant association for most PFAS, and mechanistic studies have not established a direct carcinogenic pathway.

Does submitting information create an attorney-client relationship?

No. Submission requests an initial records screening only and does not create an attorney-client relationship.

Information Registry: individuals with documented AFFF Firefighting Foam exposure and a confirmed Testicular Cancer diagnosis may request an independent eligibility review. [Begin Assessment]

References

Check Whether Your Situation Qualifies

Free and confidential. No obligation — an initial records screening only.

This page is for educational and informational purposes only and is not medical or legal advice. Consult a licensed professional for case-specific guidance.